van Beek I - Search Results

1

An overview of take-home naloxone programs in Australia.

Dwyer R, Olsen A, Fowlie C, Gough C, van Beek I, Jauncey M, Lintzeris N, Oh G, Dicka J, Fry CL, Hayllar J, Lenton S. Dwyer R, et al. Among authors: van beek i. Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812. Drug Alcohol Rev. 2018. PMID: 29744980

2

Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.

Chronister KJ, Lintzeris N, Jackson A, Ivan M, Dietze PM, Lenton S, Kearley J, van Beek I. Chronister KJ, et al. Among authors: van beek i. Drug Alcohol Rev. 2018 May;37(4):464-471. doi: 10.1111/dar.12400. Epub 2016 Apr 13. Drug Alcohol Rev. 2018. PMID: 27071354

3

Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs.

Dietze PM, Draper B, Olsen A, Chronister KJ, van Beek I, Lintzeris N, Dwyer R, Nelson M, Lenton S. Dietze PM, et al. Among authors: van beek i. Drug Alcohol Rev. 2018 May;37(4):472-479. doi: 10.1111/dar.12680. Epub 2018 Feb 22. Drug Alcohol Rev. 2018. PMID: 29473245

4

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.

Dietze P, Jauncey M, Salmon A, Mohebbi M, Latimer J, van Beek I, McGrath C, Kerr D. Dietze P, et al. Among authors: van beek i. JAMA Netw Open. 2019 Nov 1;2(11):e1914977. doi: 10.1001/jamanetworkopen.2019.14977. JAMA Netw Open. 2019. PMID: 31722024 Free PMC article. Clinical Trial.

5

Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre.

Kimber J, Mattick RP, Kaldor J, van Beek I, Gilmour S, Rance JA. Kimber J, et al. Among authors: van beek i. Drug Alcohol Rev. 2008 Nov;27(6):602-12. doi: 10.1080/09595230801995668. Drug Alcohol Rev. 2008. PMID: 19378444

6

The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia.

Degenhardt L, Roxburgh A, van Beek I, Hall WD, Robinson MK, Ross J, Mant A. Degenhardt L, et al. Among authors: van beek i. Drug Alcohol Rev. 2008 Mar;27(2):145-51. doi: 10.1080/09595230701829413. Drug Alcohol Rev. 2008. PMID: 18264874

7

Substitution therapy for amphetamine users.

Shearer J, Sherman J, Wodak A, van Beek I. Shearer J, et al. Among authors: van beek i. Drug Alcohol Rev. 2002 Jun;21(2):179-85. doi: 10.1080/09595230220139082. Drug Alcohol Rev. 2002. PMID: 12188997 Review. No abstract available.

8

Acceptability of hepatitis C virus testing methods among injecting drug users.

White B, Day C, Thein HH, Doab A, Bates A, Holden J, van Beek I, Maher L. White B, et al. Among authors: van beek i. Drug Alcohol Rev. 2008 Nov;27(6):666-70. doi: 10.1080/09595230801956116. Drug Alcohol Rev. 2008. PMID: 19378449

9

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.

Read P, Lothian R, Chronister K, Gilliver R, Kearley J, Dore GJ, van Beek I. Read P, et al. Among authors: van beek i. Int J Drug Policy. 2017 Sep;47:209-215. doi: 10.1016/j.drugpo.2017.05.032. Epub 2017 Jun 4. Int J Drug Policy. 2017. PMID: 28587943

10

Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.

Day CA, White B, Dore GJ, van Beek I, Rodgers C, Cunningham P, Wodak A, Maher L. Day CA, et al. Among authors: van beek i. Drug Alcohol Depend. 2010 Apr 1;108(1-2):134-7. doi: 10.1016/j.drugalcdep.2009.11.013. Epub 2010 Jan 4. Drug Alcohol Depend. 2010. PMID: 20047803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters